The PREVIEW intervention study: Results from a 3-year randomized 2 x 2 factorial multinational trial investigating the role of protein, glycaemic index and physical activity for prevention of type 2 diabetes.

Anne Raben, Pia Siig Vestentoft, Jennie Brand-Miller, Elli Jalo, Mathjis Drummen, Liz Simpson, J Alfredo Martinez, Teodora Handjieva-Darlenska, Gareth Stratton, Maija Huttunen-Lenz, Tony Lam, Jouko Sundvall, Roslyn Muirhead, Sally Poppitt, Christian Ritz, Kirsi H Pietiläinen, Margriet Westerterp-Plantenga, Moira A Taylor, Santiago Navas-Carretero, Svetoslav Handjiev, Melitta A McNarry, Sylvia Hansen, Laura Råman, Shannon Brodie, Marta P Silvestre, Tanja C Adam, Ian A Macdonald, Rodrigo San-Cristobal, Nadka Boyadjieva, Kelly A Mackintosh, Wolfgang Schlicht, Amy Liu, Thomas M Larsen, Mikael Fogelholm

Journal: Diabetes, obesity & metabolism 2021;23(2):324-337

PMID: 33026154

Plain Language Summary

plain language summary logo

The main risk for the development of type 2 diabetes is being overweight or obese. Strategies to decrease weight are important to prevent its development or reverse disease. This long-term, randomised control trial of 2326 adults with prediabetes, aimed to compare the effectiveness of different maintenance diets, after initial weight loss; one which was high protein and low glycaemic index, and the other which was moderate protein and moderate glycaemic index. These diets were then combined with either moderate intensity or high intensity exercise. The results showed that after 3 years, the incidence of type 2 diabetes was low and did not differ between the diet and exercise groups. However, more individuals achieved normal blood sugar levels when on a moderate protein diet combined with moderate exercise and when on a high protein diet combined with moderate exercise. The high protein diet with high intensity exercise was the least effective at maintaining normal blood sugar levels. The amount of weight lost was the same no matter what combination of diet and exercise. It was concluded that the incidence of type 2 diabetes was lower than expected with the diet and exercise regimes and did not differ between the diets. This study could be used by healthcare professionals to introduce a long-term protocol combining weight loss, healthy eating, and physical activity to pre diabetic individuals who want to reduce their chance of developing type 2 diabetes.

Abstract

AIM

To compare the impact of two long-term weight-maintenance diets, a high protein (HP) and low glycaemic index (GI) diet versus a moderate protein (MP) and moderate GI diet, combined with either high intensity (HI) or moderate intensity physical activity (PA), on the incidence of type 2 diabetes (T2D) after rapid weight loss.

MATERIALS AND METHODS

A 3-year multicentre randomized trial in eight countries using a 2 x 2 diet-by-PA factorial design was conducted. Eight-week weight reduction was followed by a 3-year randomized weight-maintenance phase. In total, 2326 adults (age 25-70 years, body mass index ≥ 25 kg/m ) with prediabetes were enrolled. The primary endpoint was 3-year incidence of T2D analysed by diet treatment. Secondary outcomes included glucose, insulin, HbA1c and body weight.

RESULTS

The total number of T2D cases was 62 and the cumulative incidence rate was 3.1%, with no significant differences between the two diets, PA or their combination. T2D incidence was similar across intervention centres, irrespective of attrition. Significantly fewer participants achieved normoglycaemia in the HP compared with the MP group (P < .0001). At 3 years, normoglycaemia was lowest in HP-HI (11.9%) compared with the other three groups (20.0%-21.0%, P < .05). There were no group differences in body weight change (-11% after 8-week weight reduction; -5% after 3-year weight maintenance) or in other secondary outcomes.

CONCLUSIONS

Three-year incidence of T2D was much lower than predicted and did not differ between diets, PA or their combination. Maintaining the target intakes of protein and GI over 3 years was difficult, but the overall protocol combining weight loss, healthy eating and PA was successful in markedly reducing the risk of T2D. This is an important clinically relevant outcome.

© 2020 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.

Address: Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Frederiksberg, Denmark.; School of Life and Environmental Sciences and Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Department of Food and Nutrition, University of Helsinki, Helsinki, Finland.; Department of Nutrition and Movement Sciences, NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.; Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, MRC/ARUK Centre for Musculoskeletal Ageing Research, ARUK Centre for Sport, Exercise and Osteoarthritis, National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham, UK.; Centre for Nutrition Research, University of Navarra, Pamplona, Spain.; Centro de Investigacion Biomedica en Red Area de Fisiologia de la Obesidad y la Nutricion (CIBEROBN), Madrid, Spain.; IdisNA Instituto for Health Research, Pamplona, Spain.; Precision Nutrition and Cardiometabolic Health Program. IMDEA-Food Institute (Madrid Institute for Advanced Studies), CEI UAM + CSIC, Madrid, Spain.; Department of Pharmacology and Toxicology, Medical University of Sofia, Sofia, Bulgaria.; College of Engineering, Applied Sports, Technology, Exercise and Medicine (A-STEM) Research Centre, Swansea, UK.; Exercise and Health Sciences, University of Stuttgart, Stuttgart, Germany.; Institute of Nursing Science, University of Education Schwäbisch Gmünd, Schwäbisch Gmünd, Germany.; NetUnion sarl, Lausanne, Switzerland.; Department of Government Services, Forensic Toxicology Unit, Biochemistry Laboratory, National Institute for Health and Welfare, Helsinki, Finland.; Human Nutrition Unit, School of Biological Sciences, Department of Medicine, University of Auckland, Auckland, New Zealand.; Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki and Obesity Centre, Endocrinology, Abdominal Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham, UK.; Centre for Nutrition Research, University of Navarra, Pamplona, Spain.; Centro de Investigacion Biomedica en Red Area de Fisiologia de la Obesidad y la Nutricion (CIBEROBN), Madrid, Spain.; IdisNA Instituto for Health Research, Pamplona, Spain.; Exercise and Health Sciences, University of Stuttgart, Stuttgart, Germany.; Human Nutrition Unit, School of Biological Sciences, Department of Medicine, University of Auckland, Auckland, New Zealand.; CINTESIS - Centro de Investigação em Tecnologias e Serviços de Saúde NOVA Medical School, NOVA University of Lisbon, Lisbon, Portugal.; Centre for Nutrition Research, University of Navarra, Pamplona, Spain.; Precision Nutrition and Cardiometabolic Health Program. IMDEA-Food Institute (Madrid Institute for Advanced Studies), CEI UAM + CSIC, Madrid, Spain.

Patient Centred Factor

Laboratory Testing

Modifiable Lifestyle Factors

Jadad Score

Allocation Concealment

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.